Cargando…
Dexmedetomidine inhibits abnormal muscle hypertrophy of myofascial trigger points via TNF-α/ NF-κB signaling pathway in rats
Myofascial pain syndrome (MPS) is a chronic pain disorder with inflammation-related primarily characterized by the presence of myofascial trigger points (MTrPs). Myocyte enhancer factor 2C (MEF2C) is involved in the occurrence of a variety of skeletal muscle diseases. However, it is not yet clear if...
Autores principales: | Liu, Mingjian, Liu, Yu, Li, Xuan, Pei, Miao, Han, Mei, Qi, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669483/ https://www.ncbi.nlm.nih.gov/pubmed/36408215 http://dx.doi.org/10.3389/fphar.2022.1031804 |
Ejemplares similares
-
Etiology of Myofascial Trigger Points
por: Bron, Carel, et al.
Publicado: (2012) -
An Herbal Product Alleviates Bleomycin-Induced Pulmonary Fibrosis in Mice via Regulating NF-κB/TNF-α Signaling in Macrophages
por: Jing, Fei, et al.
Publicado: (2022) -
Myofascial trigger points in migraine and tension-type headache
por: Do, Thien Phu, et al.
Publicado: (2018) -
Efficacy of myofascial trigger point deactivation for tinnitus control
por: Rocha, Carina Bezerra, et al.
Publicado: (2015) -
Loganin Inhibits Angiotensin II–Induced Cardiac Hypertrophy Through the JAK2/STAT3 and NF-κB Signaling Pathways
por: Xu, Jia-jia, et al.
Publicado: (2021)